0001209726-11-000001.txt : 20111017
0001209726-11-000001.hdr.sgml : 20111017
20111017120700
ACCESSION NUMBER: 0001209726-11-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111014
FILED AS OF DATE: 20111017
DATE AS OF CHANGE: 20111017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BUCHI J KEVIN
CENTRAL INDEX KEY: 0001209726
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19119
FILM NUMBER: 111143280
MAIL ADDRESS:
STREET 1: 41 MOORES ROAD
CITY: FRAZER
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEPHALON INC
CENTRAL INDEX KEY: 0000873364
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232484489
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 MOORES ROAD
CITY: FRAZER
STATE: PA
ZIP: 19355
BUSINESS PHONE: 6103440200
MAIL ADDRESS:
STREET 1: 41 MOORES ROAD
CITY: FRAZER
STATE: PA
ZIP: 19355
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0304
4
2011-10-14
1
0000873364
CEPHALON INC
CEPH
0001209726
BUCHI J KEVIN
41 MOORES ROAD
FRAZER
PA
19355
1
1
0
0
Chief Executive Officer
Common Stock
2011-10-14
4
D
0
172962
D
0
D
Common Stock
2011-10-14
4
D
0
2592
D
0
I
By Trust
Incentive Stock Option
71.96
2011-10-14
4
D
0
1264
D
2005-12-20
2011-12-20
Common Stock
1264
0
D
Incentive Stock Option
71.96
2011-10-14
4
D
0
125
D
2005-12-20
2011-12-20
Common Stock
125
0
D
Non-Qualified Stock Option
71.96
2011-10-14
4
D
0
45736
D
2005-12-20
2011-12-20
Common Stock
45736
0
D
Non-Qualified Stock Option
71.96
2011-10-14
4
D
0
375
D
2005-12-20
2011-12-20
Common Stock
375
0
D
Non-Qualified Stock Option
51.17
2011-10-14
4
D
0
55000
D
2006-12-20
2012-12-20
Common Stock
55000
0
D
Incentive Stock Option
48.2
2011-10-14
4
D
0
4148
D
2007-12-17
2013-12-17
Common Stock
4148
0
D
Non-Qualified Stock Option
48.2
2011-10-14
4
D
0
20852
D
2007-12-17
2013-12-17
Common Stock
20852
0
D
Incentive Stock Option
48.06
2011-10-14
4
D
0
2080
D
2008-12-16
2014-12-16
Common Stock
2080
0
D
Non-Qualified Stock Option
48.06
2011-10-14
4
D
0
17920
D
2008-12-16
2014-12-16
Common Stock
17920
0
D
Incentive Stock Option
51.08
2011-10-14
4
D
0
1957
D
2009-12-01
2015-12-01
Common Stock
1957
0
D
Non-Qualified Stock Option
51.08
2011-10-14
4
D
0
48043
D
2009-12-01
2015-12-01
Common Stock
48043
0
D
Incentive Stock Option
71.07
2011-10-14
4
D
0
1407
D
2010-12-19
2016-12-19
Common Stock
1407
0
D
Non-Qualified Stock Option
71.07
2011-10-14
4
D
0
48593
D
2010-12-19
2016-12-19
Common Stock
48593
0
D
Incentive Stock Option
76.11
2011-10-14
4
D
0
1313
D
2011-12-13
2017-12-13
Common Stock
1313
0
D
Non-Qualified Stock Option
76.11
2011-10-14
4
D
0
48687
D
2011-12-13
2017-12-13
Common Stock
48687
0
D
Incentive Stock Option
73.25
2011-10-14
4
D
0
1365
D
2012-12-11
2018-12-11
Common Stock
1365
0
D
Non-Qualified Stock Option
73.25
2011-10-14
4
D
0
48635
D
2012-12-11
2018-12-11
Common Stock
48635
0
D
Incentive Stock Option
56.07
2011-10-14
4
D
0
1784
D
2013-12-02
2019-12-02
Common Stock
1784
0
D
Non-Qualified Stock Option
56.07
2011-10-14
4
D
0
48216
D
2013-12-02
2019-12-02
Common Stock
48216
0
D
Incentive Stock Option
63.11
2011-10-14
4
D
0
1584
D
2014-12-16
2020-12-16
Common Stock
1584
0
D
Non-Qualified Stock Option
63.11
2011-10-14
4
D
0
78416
D
2014-12-16
2020-12-16
Common Stock
78416
0
D
Incentive Stock Option
59.4
2011-10-14
4
D
0
1683
D
2015-02-01
2021-02-01
Common Stock
1683
0
D
Non-Qualified Stock Option
59.4
2011-10-14
4
D
0
68317
D
2015-02-01
2021-02-01
Common Stock
68317
0
D
Common Stock was converted pursuant to the Agreement and Plan of Merger, dated as of May 1, 2011, among Teva Pharmaceutical Industries Ltd., Copper Acquisition Corp. and Cephalon, Inc. (the "Merger Agreement") into the right to receive the Merger Consideration (as defined in the Merger Agreement) of $81.50 per share in cash.
Includes 72,500 shares of Restricted Stock with certain vesting restrictions, which restrictions lapsed under the terms of the Merger Agreement at the Effective Time of the Merger.
Options were canceled at the Effective Time of the Merger pursuant to the terms of the Merger Agreement in exchange for a cash payment for each share subject to the option equal to the difference between the Merger Consideration of $81.50 per share and the exercise price of the option.
Reflects four-year anniversary from date of grant. Options vest 25% on each anniversary of grant and expire ten years from date of grant.
Carolyn S. Iosca, Attorney-in-Fact for Kevin Buchi
2011-10-17